Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ervin Fodor

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Molecular Cell|June 19, 2018
A Mechanism for the Activation of the Influenza Virus TranscriptaseItziar Serna Martin, Narin Hengrung, Max Renner, et al.
Nucleic Acids Research|May 31, 2022
The C-terminal LCAR of host ANP32 proteins interacts with the influenza A virus nucleoprotein to promote the replication of the viral RNA genomeFangzheng Wang, Carol M Sheppard, Bhakti Mistry, et al.
Journal of Virology|March 18, 2011
The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexesNicole C Robb, Geoffrey Chase, Katja Bier, et al.
Molecular Cell|October 20, 2018
A Mechanism for the Activation of the Influenza Virus TranscriptaseItziar Serna Martin, Narin Hengrung, Max Renner, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerasesAlexander P Walker, Haitian Fan, Jeremy R Keown, et al.
Nucleic Acids Research|April 29, 2025
Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRETDanielle Groves, Rory Cunnison, Andrew McMahon, et al.
Science Advances|December 13, 2024
Effect of pandemic influenza A virus PB1 genes of avian origin on viral RNA polymerase activity and pathogenicityStephanie L Williams, Li Qi, Zong-Mei Sheng, et al.
Plos Pathogens|November 13, 2012
Mapping the phosphoproteome of influenza A and B viruses by mass spectrometryEdward C Hutchinson, Eleanor M Denham, Benjamin Thomas, et al.
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
Nature|November 19, 2020
Host ANP32A mediates the assembly of the influenza virus replicaseLoïc Carrique, Haitian Fan, Alexander P Walker, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Molecular Cell|June 19, 2018
A Mechanism for the Activation of the Influenza Virus TranscriptaseItziar Serna Martin, Narin Hengrung, Max Renner, et al.
Nucleic Acids Research|May 31, 2022
The C-terminal LCAR of host ANP32 proteins interacts with the influenza A virus nucleoprotein to promote the replication of the viral RNA genomeFangzheng Wang, Carol M Sheppard, Bhakti Mistry, et al.
Journal of Virology|March 18, 2011
The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexesNicole C Robb, Geoffrey Chase, Katja Bier, et al.
Molecular Cell|October 20, 2018
A Mechanism for the Activation of the Influenza Virus TranscriptaseItziar Serna Martin, Narin Hengrung, Max Renner, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Enisamium is a small molecule inhibitor of the influenza A virus and SARS-CoV-2 RNA polymerasesAlexander P Walker, Haitian Fan, Jeremy R Keown, et al.
Nucleic Acids Research|April 29, 2025
Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRETDanielle Groves, Rory Cunnison, Andrew McMahon, et al.
Science Advances|December 13, 2024
Effect of pandemic influenza A virus PB1 genes of avian origin on viral RNA polymerase activity and pathogenicityStephanie L Williams, Li Qi, Zong-Mei Sheng, et al.
Plos Pathogens|November 13, 2012
Mapping the phosphoproteome of influenza A and B viruses by mass spectrometryEdward C Hutchinson, Eleanor M Denham, Benjamin Thomas, et al.
Virology|December 31, 2002
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse geneticsKanta Subbarao, Hualan Chen, David Swayne, et al.
Nature|November 19, 2020
Host ANP32A mediates the assembly of the influenza virus replicaseLoïc Carrique, Haitian Fan, Alexander P Walker, et al.
Pageof 11